Mumbai, Dec 15: The initial public offering (IPO) of Park Medi World received overwhelming response, being subscribed 8.10 times. Investors bid for 33.88 crore shares against the 4.18 crore shares on offer.
The IPO witnessed strong participation across categories: Non-Institutional Investors (NII) 15.15x, Qualified Institutional Buyers (QIB) 11.48x, and Retail Individual Investors (RII) 3.16x. The issue was open for subscription from December 10 to December 12, 2025, with a price band of Rs 154-162 per share.
IPO Structure and Objectives
The issue comprised a fresh equity issue of Rs 770 crore and an offer for sale of Rs 150 crore by existing shareholder Dr. Ajit Gupta. The fresh issue proceeds are earmarked for:
Rs 380 crore: Repayment/prepayment of outstanding borrowings
Rs 60.5 crore: Capital expenditure for a new hospital by subsidiary Park Medicity (NCR)
Rs 27.45 crore: Purchase of medical equipment for the company and subsidiaries Blue Heavens and Ratnagiri
Remaining funds: Inorganic acquisitions and general corporate purposes
Post-IPO, promoters Dr. Ajit Gupta and Dr. Ankit Gupta along with their group are expected to hold 82.89% of equity.
Company Profile
Park Medi World is a leading private hospital chain in North India with 3,250 beds across 14 NABH-accredited multi-specialty hospitals—the largest in Haryana. It offers 30+ specialties, including internal medicine, neurology, urology, gastroenterology, orthopedics, and oncology, supported by 1,014 doctors and 2,142 nurses.
The chain is expanding with new hospitals in Ambala, Panchkula, Rohtak, Gorakhpur, and Kanpur, targeting a total capacity of 4,900 beds by FY28. Revenue is primarily driven by internal medicine (29.65%) and government schemes (83.38%). Current bed occupancy stands at 68.14%, with 46,551 inpatients and 3,92,049 outpatients in nine months ending June 31, 2025.
Anchor Investors
Ahead of the IPO, the company raised Rs 275.99 crore from anchor investors on December 9, 2025, allotting 1.70 crore shares at Rs 162 each to 23 anchor investors.
The company reported a consolidated net profit of Rs 139.14 crore and income from operations of Rs 808.66 crore for the nine months ended June 31, 2025.